- Home
- AIOT vs DAWN Comparison
AIOT vs DAWN Comparison
Compare AIOT & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIOT
- DAWN
- Stock Information
- Founded
- AIOT 1993
- DAWN 2018
- Country
- AIOT United States
- DAWN United States
- Employees
- AIOT N/A
- DAWN N/A
- Industry
- AIOT Telecommunications Equipment
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- AIOT Telecommunications
- DAWN Health Care
- Exchange
- AIOT Nasdaq
- DAWN Nasdaq
- Market Cap
- AIOT 594.8M
- DAWN 624.8M
- IPO Year
- AIOT N/A
- DAWN 2021
- Fundamental
- Price
- AIOT $5.42
- DAWN $7.30
- Analyst Decision
- AIOT Strong Buy
- DAWN Strong Buy
- Analyst Count
- AIOT 4
- DAWN 7
- Target Price
- AIOT $10.50
- DAWN $27.86
- AVG Volume (30 Days)
- AIOT 1.5M
- DAWN 1.3M
- Earning Date
- AIOT 11-11-2025
- DAWN 10-29-2025
- Dividend Yield
- AIOT N/A
- DAWN N/A
- EPS Growth
- AIOT N/A
- DAWN N/A
- EPS
- AIOT N/A
- DAWN N/A
- Revenue
- AIOT $391,206,000.00
- DAWN $187,638,000.00
- Revenue This Year
- AIOT $21.83
- DAWN $12.69
- Revenue Next Year
- AIOT $10.13
- DAWN $48.51
- P/E Ratio
- AIOT N/A
- DAWN N/A
- Revenue Growth
- AIOT 119.82
- DAWN 2190.50
- 52 Week Low
- AIOT $3.70
- DAWN $5.64
- 52 Week High
- AIOT $8.71
- DAWN $16.76
- Technical
- Relative Strength Index (RSI)
- AIOT 59.77
- DAWN 53.26
- Support Level
- AIOT $5.09
- DAWN $6.70
- Resistance Level
- AIOT $5.55
- DAWN $8.28
- Average True Range (ATR)
- AIOT 0.24
- DAWN 0.36
- MACD
- AIOT -0.03
- DAWN 0.06
- Stochastic Oscillator
- AIOT 58.21
- DAWN 39.32
About AIOT PowerFleet Inc. Common Stock
PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.